FEN1 and ductal breast carcinoma in situ: This study showed a positive correlation between high FEN1 protein levels with aggressive clinicopathological parameters including hormone status negativity, which can promote FEN1 as a good candidate biomarker for prognostication of DCIS according to their hormonal status.